Pliant Therapeutics Announces Upcoming Presentation of Phase 1 Clinical Trial of PLN-101095 in Patients with Solid Tumors at the 2026 AACR Annual Meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/4/2026

1. KRG
2. PRYMY
3. SPY
4. SKA-B
5. PBA
6. ALAR
7. CCH:LN
8. META
9. CCHGY
10. PRY:IM

Go back to Pliant Therapeutics Announces Upcoming Presentation of Phase 1 Clinical Trial of PLN-101095 in Patients with Solid Tumors at the 2026 AACR Annual Meeting
(NASDAQ: PLRX) Delayed: 1.17 +0.06 (5.41%)
Previous Close $1.11    52 Week High $ 
Open $1.11    52 Week Low $ 
Day High $1.18    P/E N/A 
Day Low $1.11    EPS $ 
Volume 702,120